Search

Michael Anthony Ihnat

from Mustang, OK
Age ~60

Michael Ihnat Phones & Addresses

  • 330 N Pebble Creek Ter APT 302, Mustang, OK 73064 (405) 326-3808
  • 210 N Pebble Creek Ter #202, Mustang, OK 73064
  • 210 Pebble Creek Ter, Mustang, OK 73064
  • 706 Pecan St, Tuttle, OK 73089 (580) 320-1691
  • 354 Shadowlawn Ave, Pittsburgh, PA 15216
  • 4810 Brandt Cir, Columbus, OH 43230
  • 5029 Marden Ct, Columbus, OH 43230
  • Gahanna, OH
  • Lebanon, NH
  • Lynnwood, WA

Resumes

Resumes

Michael Ihnat Photo 1

Co-Owner Byboa And Camera Operator For

View page
Work:
Byboa Productions and Morgan Films Entertainment
Co-Owner Byboa and Camera Operator For Morgan Films


Co-Owner Byboa and Camera Operator For
Education:
Florida Metropolitan University 2003 - 2006
Associates, Film
Skills:
Research
Hospitality
Camera Operation
Corporate Events
Microsoft Excel
Powerpoint
English
Budgets
Lighting
Microsoft Word
Video Production
Customer Service
Microsoft Office
Outlook
Troubleshooting
Michael Ihnat Photo 2

Michael Ihnat

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Michael J. Ihnat
PORT CLINTON FIREFIGHTERS ASSOCIATION, INC
Michael Ihnat
Director
Dormatarg, Inc
Development of Anti-Cancer Drugs
940 Stanton L Young Blvd, Oklahoma City, OK 73104
940 Stanton Young Blvd, Oklahoma City, OK 73104
(405) 641-9473, (405) 271-6289

Publications

Us Patents

In Vivo Methods Of Identifying Compounds Which Target Suppressed Cancer Cells

View page
US Patent:
8101159, Jan 24, 2012
Filed:
Aug 13, 2009
Appl. No.:
12/540821
Inventors:
Robert E. Hurst - Oklahoma City OK, US
Michael A. Ihnat - Tuttle OK, US
Assignee:
The Board of Regents of the University of Oklahoma - Oklahoma City OK
International Classification:
A61K 49/00
A61K 49/14
A61K 31/33
A61K 31/215
A61K 31/165
A61K 31/135
US Classification:
424 92, 514183, 514529, 514617, 514646
Abstract:
In vitro and in vivo methods for identifying compounds capable of targeting suppressed cancer cells such as micrometastatic cells. The in vitro method includes the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix. The in vivo method includes a step of co-injecting labeled cancer cells with a malignant-phenotype suppressing matrix into a test animal to produce suppressed micrometastatic cells therein.

Method Of Identification Of Compounds Effective Against Suppressed Cancer Cells

View page
US Patent:
7575926, Aug 18, 2009
Filed:
Dec 19, 2006
Appl. No.:
11/642313
Inventors:
Robert E. Hurst - Oklahoma City OK, US
Michael A. Ihnat - Tuttle OK, US
Kimberly D. Kyker - Oklahoma City OK, US
Assignee:
The Board of Regents of the University of Oklahoma - Norman OK
International Classification:
C12N 5/06
C12N 5/08
US Classification:
435374, 435375, 435377, 435395
Abstract:
A method for identifying compounds capable of targeting suppressed cancer cells, the method including the steps of comparing the response to a test compound of cancer cells grown on a suppressing cell support matrix which causes suppression of a malignant phenotype in a growing cancer cell and on a non-suppressing cell support matrix.
Michael Anthony Ihnat from Mustang, OK, age ~60 Get Report